Compare ITIC & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ITIC | TOI |
|---|---|---|
| Founded | 1972 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 517.1M | 444.1M |
| IPO Year | N/A | N/A |
| Metric | ITIC | TOI |
|---|---|---|
| Price | $251.96 | $3.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 19.3K | ★ 1.9M |
| Earning Date | 02-12-2026 | 11-13-2025 |
| Dividend Yield | ★ 6.30% | N/A |
| EPS Growth | ★ 25.81 | N/A |
| EPS | ★ 19.00 | N/A |
| Revenue | $273,864,000.00 | ★ $461,039,000.00 |
| Revenue This Year | N/A | $28.51 |
| Revenue Next Year | N/A | $23.54 |
| P/E Ratio | $13.23 | ★ N/A |
| Revenue Growth | 13.63 | ★ 21.67 |
| 52 Week Low | $190.20 | $0.20 |
| 52 Week High | $288.98 | $4.88 |
| Indicator | ITIC | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 44.53 | 50.91 |
| Support Level | $250.26 | $3.23 |
| Resistance Level | $260.66 | $3.90 |
| Average True Range (ATR) | 7.32 | 0.24 |
| MACD | 0.30 | 0.02 |
| Stochastic Oscillator | 51.41 | 52.48 |
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.